-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-09-04
Build a delivery workflow that separates where mRNA goes from whether it translates. EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) combines direct Cy5 tracking with quantitative luciferase output for transfection optimization, trafficking studies, and in vivo imaging.
-
Fluconazole Mechanism and Research Benchmarks
2026-09-04
Fluconazole is a fungal cytochrome P450 enzyme 14α-demethylase inhibitor that disrupts ergosterol biosynthesis. This article consolidates product benchmarks, Candida albicans model parameters, formulation guidance, and the research boundary between pharmacological inhibition and newly described mucosal antifungal defense.
-
Crystal Violet Staining Solution for Cell Assays
2026-09-03
Use Crystal Violet Staining Solution as a practical nuclear staining dye for endpoint imaging and biomass quantification across colony, migration, and invasion workflows. This guide connects optimized cell-assay execution with phenotype-focused lessons from recent Candidozyma auris research while clearly separating validated evidence from starting-point recommendations.
-
SIRT7, AKT/mTOR, and Periodontal Cell Senescence
2026-09-03
The reference study links reduced SIRT7 in Porphyromonas gingivalis lipopolysaccharide-treated human periodontal ligament fibroblasts with cellular senescence and inflammatory signaling. Bidirectional SIRT7 manipulation associates these effects with AKT/mTOR phosphorylation, providing a mechanistic framework for studying periodontal inflammation while highlighting the limits of extrapolation beyond this cell model.
-
CD38 CAR Binder Structures and Affinity Tuning
2026-09-02
This iScience study explains how two CD38-targeting CAR binders, RP02 and 028, recognize the antigen through different structural mechanisms and produce distinct effects on CD38 enzymatic activity. By combining crystallography, alanine scanning, biochemical assays, and engineered CAR-T cells, the authors show that rational affinity attenuation can reduce fratricide while preserving antitumor cytotoxicity.
-
Ionizable Lipids for Organ-Selective mRNA Delivery
2026-09-02
A 2023 Angewandte Chemie study used the Ugi four-component reaction to rapidly diversify ionizable lipids for mRNA lipid nanoparticles. Its results show that small structural changes, including isomerism and molecular skeleton design, can shift delivery performance between the liver and spleen while also influencing nanoparticle stability.
-
O-GlcNAc–HUWE1–TfR1 Axis in Preeclampsia
2026-09-01
The reference study identifies an O-GlcNAc–HUWE1–TfR1 regulatory axis that connects trophoblast ferroptosis, iron handling, and syncytialization defects in preeclampsia. By combining placental analyses, O-GlcNAc proteomics, trophoblast models, and mouse experiments, the work provides a mechanistic framework for testing O-GlcNAc-centered interventions in placental disease.
-
TMRE and the Bioenergetics of Sodium-Driven Cell Death
2026-09-01
A mechanistic and translational guide to using TMRE fluorescence to connect sodium-driven mitochondrial energy failure with apoptosis research, mitochondrial function analysis, and experimentally defensible assay design.
-
Rational n-Alkyl Design of Copper Ionophores
2026-08-31
The reference study shows that simple n-alkyl chain modification can substantially tune copper-ionophore performance, with C6 providing the best balance of copper binding, lipophilicity, and intracellular transport. C6 induced cuproptosis-associated mitochondrial damage in triple-negative breast cancer models while retaining low systemic toxicity and producing antitumor and immunomodulatory effects.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow Guide
2026-08-31
Build a two-channel assay that separates mRNA delivery from protein expression in mammalian cells. This workflow uses Cy5 to track intracellular cargo and EGFP to quantify translation, making it practical for comparing transfection reagents, lipid nanoparticles, and emerging delivery systems.
-
ZNF263, ULK1, and Autophagy in ICC
2026-08-30
This reference study identifies ZNF263 as an enhancer-associated transcriptional regulator that promotes intrahepatic cholangiocarcinoma proliferation through the ULK1–autophagy axis. By combining tissue analysis, genetic perturbation, CUT&Tag, RNA sequencing, chromatin validation, reporter assays, and xenograft experiments, it connects ZNF263-mediated gene expression regulation with a functional cancer phenotype.
-
EZ Cap™ Firefly Luciferase mRNA Workflow
2026-08-29
Build sensitive, reproducible reporter assays with Cap1- and poly(A)-optimized EZ Cap™ Firefly Luciferase mRNA. This practical guide covers delivery, translation readouts, in vivo imaging, upstream RNA-quality considerations, and troubleshooting from sample preparation through data normalization.
-
Entecavir Workflows for HBV Replication Studies
2026-08-28
Build reproducible HBV replication assays around Entecavir, from DMSO stock preparation and nanomolar dose-response testing to resistant-strain comparisons and translational interpretation. The workflow separates compound handling, assay controls, and clinical context so researchers can distinguish genuine polymerase inhibition from model or dosing artifacts.
-
Caspase-8 Fluorometric Assay Kit in Therapy Studies
2026-08-28
The Caspase-8 Fluorometric Assay Kit provides a functional readout of IETD-dependent protease activity for therapy-response studies. This article explains how to use caspase-8 activity measurement to distinguish enzyme activation, protein accumulation, apoptosis, and pyroptosis.
-
Vorinostat and mRNA Lipoplex Protein Expression
2026-08-27
This 2024 study examined whether the HDAC inhibitor vorinostat could increase protein production after mRNA lipoplex delivery. Low-dose vorinostat enhanced luciferase expression in HeLa and HepG2 cells, but its effects in mice were modest and differed between tissue distribution and functional protein output.